Azenta Inc. (AZTA)

FairStock Score: 25/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable earnings and a margin of safety. Azenta provides biological and chemical sample exploration and management solutions to life-sciences customers, a niche that can have sticky consumables and switching costs, but the numbers show a company still searching for consistent profitability. In fiscal Q3 2026, the quarter ended 2026-06-30, revenue was $161.2M and net income was $2.5M, a thin 1.5% margin. Before that, fiscal Q2 2026, ended 2026-03-31, produced a $160.8M net loss, and fiscal Q1 2026, ended 2025-12-31, lost $15.4M. For full fiscal 2025, revenue was $593.8M but net income was negative $55.8M; fiscal 2024 lost $164.9M. Revenue is inching up, not compounding. The balance sheet is a bright spot: debt-to-equity 0.04, Altman Z-Score 3.99, Piotroski F-Score 8/9. Still, FairStock calculations show ROE of -7.04%, ROCE of -0.73%, and trailing free cash flow of only $9.9M, a 0.6% FCF yield at the 2026-10-13 close. The market cap is $1.7B and price $37.87. FairStock's P/B is 1.10, which is not demanding, but negative earnings make its P/E meaningless; its EV/EBITDA of 47.0 is high. FairStock score 25/100 and Lynch category TURNAROUND—loss latest year after earlier profits—fit. I would need evidence of durable positive earnings and better cash generation before calling this a bargain. A low price-to-book is only useful if the book value is real and the losses stop.

In plain English: Azenta helps life-science labs store, track, and study samples. The business looks weak right now: sales are barely growing, it has lost money in recent years, and the latest reported quarter was only slightly profitable. At the recent price, the shares do not look clearly cheap against those weak profits, though the company has little debt and trades near the value of its assets minus debts.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-06-30) · fiscal Q2 2026 10-Q (period ended 2026-03-31) · fiscal Q1 2026 10-Q (period ended 2025-12-31) · fiscal Q4 2025 10-K (period ended 2025-09-30) · FY2025 10-K (period ended 2025-09-30) · FY2024 10-K (period ended 2024-09-30) · FY2023 10-K (period ended 2023-09-30)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer